The first 5 pages, shown as text so search engines and readers can find this document.
Page 1
STATE-OF-THE-ART REVIEW ARTICLE
Vitamin D Deficiency in Children and Its
Management: Review of Current Knowledge and
Recommendations
Madhusmita Misra, MD, MPHa, Danie` le Pacaud, MDb, Anna Petryk, MDc, Paulo Ferrez Collett-Solberg, MDd, Michael Kappy, MD, PhDe,
on behalf of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society
aPediatric Endocrine and Neuroendocrine Units, Massachusetts General Hospital, Boston, Massachusetts; bDivision of Pediatric Endocrinology, Department of Pediatrics,
University of Calgary, Alberta Children’s Hospital, Calgary, Alberta, Canada; cDepartment of Pediatrics, University of Minnesota, Minneapolis, Minnesota; dInstituto
Estadual de Diabetes e Endocrinologia, Rio de Janeiro, Brazil; eChildren’s Hospital Association, University of Colorado Health Sciences Center, Denver, Colorado
The authors have indicated they have no financial relationships relevant to this article to disclose.
ABSTRACT
Given the recent spate of reports of vitamin D deficiency, there is a need to
reexamine our understanding of natural and other sources of vitamin D, as well as
mechanisms whereby vitamin D synthesis and intake can be optimized. This state-
of-the-art report from the Drug and Therapeutics Committee of the Lawson Wilkins
Pediatric Endocrine Society was aimed to perform this task and also reviews recom-
mendations for sun exposure and vitamin D intake and possible caveats associated
with these recommendations. Pediatrics 2008;122:398–417
VITAMIN D IS a prohormone that is essential for normal absorption of calcium
from the gut, and deficiency of vitamin D is associated with rickets in growing
children and osteomalacia in adults. Rickets is the failure of mineralization of
growing bone and cartilage. Initial descriptions of rickets were provided by Daniel
Whistler and Francis Glisson in England as early as the 17th century. At the turn of
the 20th century, with industrialization, this disease became endemic until it was
discovered that exposure to sunlight and cod liver oil could both prevent and
treat rickets.1,2 Once vitamin D was identified and easy ways to supplement foods
were developed, nutritional rickets almost disappeared from industrialized coun-
tries.1–3 However, there has been a reappearance of rickets from vitamin D
deficiency in recent decades as a result of multiple factors, which we will discuss
in the course of this review. Dark-skinned infants who are exclusively breastfed
and infants born to mothers who were vitamin D deficient through pregnancy
seem to be at particularly high risk. However, rickets is also being reported in
older children.
In North America and the United Kingdom, there are no current definitive
prevalence estimates available for vitamin D– deficiency rickets because recent pub-
lications have been mainly case reports or case series obtained from hospital admis-
sions records. The 2 largest series reported 126 cases over a period of 10 years in
Australia4 and 104 cases over 2 years in Canada.5 Reported and published cases of
nutritional rickets in the United States increased from 65 between 1975 and 1985 to
166 between 1986 and 2003.6 Since then, 3 reports added another 62 cases to the
American literature.7–9 It should also be recognized that in other parts of the world,
nutritional rickets remains a public health problem.10–13
In 2003, the American Academy of Pediatrics (AAP) recommended a vitamin D supplement for (1) breastfed
infants who do not consume at least 500 mL of a vitamin D–fortified formula/beverage14 and (2) nonbreastfed infants
who do not consume 500 mL of vitamin D–fortified beverages. The supplementation should start during the first
2 months of life and continue throughout childhood and adolescence. The rationale for this timing is that vitamin D
stores in the newborn, which are obtained through transplacental passage from the vitamin D–replete mother,
should last for at least 8 weeks after delivery given that the half-life of serum 25(OH)-vitamin D [25(OH)-D] is 2
to 3 weeks.15 In a term infant born to a vitamin D–replete mother, the supply of vitamin D may last even longer (8 –12
weeks) given the storage of vitamin D in fat. In the United States, all infant formulas are mandated to contain 40 to
100 IU of vitamin D per 100 kcal (1 kcal 4.2 kJ) of formula (258 – 666 IU of vitamin D per L of a 20 kcal/oz
formula14,16) and, in fact, all contain at least 400 IU/L of vitamin D.17 Thus, daily intake of at least 500 mL of vitamin
D–fortified formula would ensure the required minimum daily intake of vitamin D of 200 IU/day. However, despite
current guidelines for vitamin D supplementation, rickets continues to be reported.
www.pediatrics.org/cgi/doi/10.1542/
peds.2007-1894
doi:10.1542/peds.2007-1894
This review was developed to be of
educational value to practitioners; it should
not be construed as indicating official
policy or guidelines of the Lawson Wilkins
Pediatric Endocrine Society.
Key Words
food fortification, breastfeeding, calcium,
supplements, vitamin D
Abbreviations
AAP—American Academy of Pediatrics
25(OH)-D—25(OH)-vitamin D
UVR— ultraviolet radiation
PTH—parathyroid hormone
1,25(OH)2-D—1,25-dihydroxy vitamin D
ALP—alkaline phosphatase
DBP—vitamin D– binding protein
24,25(OH)2-D—24,25-dihydroxy vitamin D
MED—minimum erythema dose
mAb—monoclonal antibody
HPLC— high-pressure liquid
chromatography
SPF—sun protection factor
Accepted for publication Nov 26, 2007
Address correspondence to Madhusmita
Misra, MD, MPH , Massachusetts General
Hospital, Pediatric Endocrine and
Neuroendocrine Units, Boston, MA 02114.
E-mail: mmisra@partners.org
PEDIATRICS (ISSN Numbers: Print, 0031-4005;
Online, 1098-4275). Copyright © 2008 by the
American Academy of Pediatrics
398 MISRA et al at Massachusetts General Hos on September 24, 2020www.aappublications.org/newsDownloaded from
Page 2
It is important to recognize that vitamin D is primarily
made in the skin after exposure to ultraviolet radiation
(UVR), and 10% is derived from dietary sources.18
Modern conditions of dress, lifestyle, and recommenda-
tions regarding sun avoidance to reduce risks of skin
cancer may prevent a large proportion of the population
from making healthy amounts of this vitamin. Over the
last 2 decades, our understanding of vitamin D synthesis
and its functions has increased markedly. This improved
understanding and the many reports of vitamin D– defi-
ciency rickets require us to reexamine traditional con-
cepts and current recommendations for vitamin D sup-
plementation and sun exposure and to develop revised
management strategies. In this review we discuss the
causes of vitamin D deficiency, particularly in relation to
natural and artificial sunblocks and maternal vitamin D
status, and current knowledge regarding prevention and
treatment of vitamin D deficiency.
EFFECT OF VITAMIN D DEFICIENCY
Calcium and Phosphorus Metabolism and Bone
In a vitamin D–sufficient state [25(OH)-D levels of 50
nmol/L (20 ng/mL)], net intestinal calcium absorption is
up to 30%, although calcium absorption can reach 60%
to 80% during periods of active growth. In a vitamin
D– deficient state, intestinal calcium absorption is only
10% to 15% and there is a decrease in the total max-
imal reabsorption of phosphate. In conditions of vitamin
D deficiency,19 low ionized calcium levels stimulate para-
thyroid hormone (PTH) secretion, which (1) increases
calcium reabsorption in renal tubules and (2) increases
1-
-hydroxylase activity, which causes increased 1,25-
dihydroxy vitamin D [1,25(OH)2-D] synthesis. Increased
PTH levels also cause phosphorus loss in urine. De-
creased levels of phosphorus (and also calcium) and
decreased calcium*phosphorus product result in de-
creased bone mineralization. In addition, the low phos-
phorus levels cause a failure of the expected apoptosis of
hypertrophied chondrocytes, with cellular “ballooning”
and disorganization of the growth plate. Failure or delay
of calcification of osteoid leads to osteomalacia in mature
bones. Osteomalacia in immature bones is referred to as
rickets. The term rickets also describes the abnormal
organization of the cartilaginous growth plate and the
accompanying impairment of cartilage mineralization.
The clinical presentation of vitamin D– deficiency
rickets includes symptoms and signs of bone deformity
and/or pain and may be associated with hypocalcemia
and associated clinical features.20. The disease can be
divided into 3 stages (Table 1). The first stage is charac-
terized by osteopenia and subclinical or overt hypocal-
cemia (usually very transitory and, therefore, undocu-
mented), which is followed in the second stage by rising
levels of PTH. Increases in PTH levels cause calcium
mobilization from bone and correction of hypocalcemia.
Demineralized collagen matrix is prone to hydration and
swelling, which causes the periosteal covering to expand
outward, and bone pain occurs, mediated by periosteal
sensory pain fibers. In the final stage, bone changes
become more severe, and hypocalcemia once again be-
comes evident.
Symptoms of rickets can range from none to varying
degrees of irritability, delay in gross motor development,
and bone pain. Signs include widening of the wrists and
ankles, genu varum or valgum, prominence of the cos-
tochondral junctions (rachitic rosary), delayed closure of
fontanelles, craniotabes, and frontal bossing. Tooth
eruption may be delayed and tooth enamel may be of
poor quality if vitamin D deficiency occurs in utero or in
early infancy, increasing the risk for caries. Rickets also
may be associated with poor growth (a manifestation of
associated bone disease) and an increased susceptibility
to infections.
Vitamin D deficiency that presents as hypocalcemic
seizures or tetany is reported more frequently in infancy
and adolescence than in childhood. At these periods of
increased growth velocity, the increased demand for
calcium cannot be met in a timely fashion, and the
patient may present with hypocalcemia even before
bone demineralization or radiologic signs of rickets are
observed.21,22 During childhood, lower metabolic de-
mand allows the body to avoid symptomatic hypocalce-
mia by drawing on bone stores of calcium secondary to
hyperparathyroidism in the second stage of the disease.
However, this occurs at the expense of depleting bone of
its calcium, which results in signs of demineralization
and subsequent bone deformity.22 Children with vitamin
D deficiency who are hypocalcemic may manifest clini-
cal features associated with hypocalcemia per se such as
apneic spells, stridor or wheezing, hypotonia, muscular
weakness, and brisk reflexes. Severe vitamin D defi-
ciency also may be associated with cardiomyopathy re-
lated to hypocalcemia, which normalizes with treat-
ment.23
The diagnosis of rickets depends on presence of the
clinical features mentioned above and radiologic and
laboratory features. Radiologic images may indicate os-
teopenia and cortical thinning of long bones, stress frac-
tures, and metaphyseal widening and fraying. The ear-
liest sign is usually osteopenia followed by a widening of
TABLE 1 Biochemical Manifestations of Different Stages of Vitamin D Deficiency
Plasma Ca Plasma PO4 ALP PTH 25(OH)-D 1,25(OH)2-D Radiograph Changes
Early N/2 N/2 1 1 2 N Osteopenia
Moderate N/2 2 11 11 22 1 Rachitic changes
Severe 22 22 111 111 222 1/N/2 Rachitic changes
N indicates normal; 1, increase; 2, decrease. mild changes, moderate to severe changes
Adapted with permission from Levine M, Zapalowski C, Kappy M. Disorders of calcium, phosphate, PTH and vitamin D metabolism. In: Kappy MS, Allen DB, Geffner ME, eds. Principles and Practice of
Pediatric Endocrinology. Springfield, IL: Charles C. Thomas Co; 2005:762.
PEDIATRICS Volume 122, Number 2, August 2008 399
at Massachusetts General Hos on September 24, 2020www.aappublications.org/newsDownloaded from
Page 3
the growth plate from proliferation of uncalcified carti-
lage and osteoid, followed by metaphyseal widening,
splaying, cupping, and fraying (Fig 1). A coarse trabec-
ular pattern is observed of the metaphysis. The earliest
rachitic change is a loss of demarcation between the
metaphysis and growth plate and loss of the provisional
zone of calcification.20 A 10-point radiographic scoring
system was developed to aid in assessment of the severity
of rickets on the basis of knee and wrist findings24 (Table 2).
Laboratory findings include hypophosphatemia, varying
degrees of hypocalcemia, increased alkaline phosphatase
(ALP), and increased PTH levels. Low levels of 25(OH)-D
confirm the diagnosis but may not be necessary when
other clinical, radiologic, and laboratory findings are un-
equivocal. Levels of 1,25(OH)2-D may become elevated as
PTH levels rise, with a concomitant increase in 1-
-
hydroxylase activity. Table 1 summarizes laboratory
findings in the 3 stages of vitamin D– deficiency rickets.25
Extraskeletal Effects of Vitamin D
The vitamin D receptor is present in the small intestine,
colon, osteoblasts, activated T and B lymphocytes,
islet
cells, and most organs in the body such as the brain,
heart, skin, gonads, prostate, breast, and mononuclear
cells. Epidemiologic studies over the last 2 decades have
suggested important effects of vitamin D on the immune
system and in preventing certain cancers; these findings
are summarized below. Although these findings have
generated great interest, the possibility of confounding
variables needs to be considered. It is important to note
that adjusted attributable risk calculated from multivar-
iate models remains considerable for many cancers in
conditions of vitamin D deficiency.26 Long-term prospec-
tive studies examining the effects of vitamin D supple-
mentation in preventing immune-mediated conditions
and cancers that may be related to vitamin D deficiency
are awaited.
Skin
Keratinocytes express the vitamin D receptor, and when
these cells are exposed to vitamin D, their growth is
inhibited and they are stimulated to differentiate.27 This
has led to the use of topical vitamin D analogs to treat
psoriasis.28
Immune Effects
Vitamin D modulates B- and T-lymphocyte function.29,30
Epidemiologic evidence exists of vitamin D deficiency
being associated with autoimmune diseases such as type
1 diabetes and multiple sclerosis.31,32 One-year-old vita-
min D– deficient children have been reported to be at a
fourfold higher risk of developing type 1 diabetes than
vitamin D–sufficient children.33 Also, the risk for multi-
ple sclerosis is higher in people who live above 35°
latitudes than in those who live below this latitude,34 and
an inverse relationship has been reported between vita-
min D concentrations and risk of multiple sclerosis.35
FIGURE 1
Vitamin D– deficiency rickets at presentation (upper) and 3
months after vitamin D and calcium therapy (lower) in a 1-year
old black boy. At presentation, radiographs of the wrist (left) and
knee (right) showed evidence of splaying, fraying, cupping, and
demineralization of the distal radial and ulnar metaphyses, the
distal metaphysis of the femur, and proximal metaphyses of the
tibia and fibula. There was widening of the physis. After therapy,
the child showed evidence of near-complete resolution of me-
taphyseal fraying with interval development of a dense provi-
sional zone of calcification in the metaphysis consistent with
healing rickets.
400 MISRA et al at Massachusetts General Hos on September 24, 2020www.aappublications.org/newsDownloaded from
Page 4
Data suggest that vitamin D–sufficient states in the
mother and infant may protect against type 1 diabetes36
and multiple sclerosis.37 Protective effects of vitamin D
supplementation have also been demonstrated against
rheumatoid arthritis38 and inflammatory bowel disease.39
Cancer
Vitamin D concentrations of 75 nmol/L (30 ng/mL)
keep cell growth in check and prevent cells from becom-
ing autonomous and developing into unregulated can-
cer,40–42 and vitamin D deficiency has been related to
breast, prostate, and colon cancer.43–48
Psychiatric Conditions
Adequate vitamin D levels in pregnancy are associated
with decreased risk of schizophrenia49; conversely, low
levels of sun exposure are associated with seasonal af-
fective disorder50 and mood disturbances.51 It is unclear,
however, whether it is decreased sun exposure or defi-
ciency of vitamin D that is related to the latter condi-
tions. Vitamin D–sufficient states in the mother and
infant are thought to be associated with a lower risk of
bipolar disorder.52 Low maternal vitamin D levels may
have an impact on fetal brain maturation, given that
vitamin D is also involved in development and function-
ing of the nervous system.53
SOURCES OF VITAMIN D
Most circulating vitamin D is synthesized from skin ex-
posure to ultraviolet B (UV-B) radiation.
Cutaneous Vitamin D Synthesis
Vitamin D synthesis by the skin is the main source of this
prohormone for most people. Vitamin D2 (ergocalcif-
erol) is plant derived, whereas vitamin D3 (cholecalcif-
erol) is synthesized by animals. Fig 2 reviews the process
of vitamin D synthesis. 7-Dehydrocholesterol (provita-
min D) is a relatively rigid, 4-ringed structure present in
the lipid bilayer of the plasma membrane of epidermal
keratinocytes and dermal fibroblasts.54 The highest con-
centrations of 7-dehydrocholesterol are found in the
stratum basale and stratum spinosum of the epidermis;
thus, these layers have the greatest capability of previ-
tamin D synthesis.55 Exposure to UV-B in the wave-
lengths of 290 to 315 nm initiates the synthesis of vita-
min D by causing double bonds in the B ring of
provitamin D to rearrange, which leads its B ring to open
and, thus, converting it to the less rigid previtamin D.
Previtamin D isomerizes to vitamin D and then is trans-
ferred to extracellular space and dermal capillaries,
where it binds with vitamin D– binding protein (DBP).
This binding ensures efficient conversion of previtamin
D to vitamin D by shifting the equilibrium toward vita-
min D. The complex of DBP with vitamin D is trans-
ported to the liver for 25-hydroxylation to 25(OH)-D
(calcidiol). Although 25(OH)-D is 2 to 5 times as potent
as vitamin D, it is not biologically active at physiologic
concentrations. 25(OH)-D is released into the circulation
and transported to the kidney bound to DBP for 1-
-
hydroxylation to 1,25(OH)2-D and for 24-hydroxylation
to 24,25-dihydroxy vitamin D [24,25(OH)2-D].56
1,25(OH)2-D (calcitriol) is the active form of vitamin D,
whereas 24,25(OH)2-D has limited, if any, physiologic ac-
tivity. Nuclear receptors for 1,25(OH)2-D are present in
30 tissues. Although specific intracellular binding pro-
teins for 24,25(OH)2-D have been identified in healing
bone tissue and cartilage at sites of fractures, a role in
fracture healing has not yet been demonstrated.57 Studies
have indicated that 1-
-hydroxylation may also occur at
sites other than the kidney, such as the alveolar macro-
TABLE 2 Radiographic Features of Rickets (a 10-Point Scoring System)
Wrista: Score both the radius and the ulna separately
Grade Radiographic features
1 Widened growth plate, irregular metaphyseal margins, but without
concave cupping
2 Metaphyseal concavity with fraying of margins
2 bones 2 points 4 points possible
Kneea: Score both the femur and tibia separately
Multiply grade in A by the multiplier in B for each
bone, and then add femur and tibia scores
A
Grade Degree of lucency and widening of zone of provisional calcification
1 Partial lucency, smooth margin of metaphysis visible
2 Partial lucency, smooth margin of metaphysis not visible
3 Complete lucency, epiphysis appears widely separated from distal
metaphysis
B
Multiplier
0.5 1 condyle or plateau
1 2 condyles or plateaus
2 bones 1 point 3 points 6 points possible
Total: 10 points possible
a Score the worst knee and the worse wrist.
Reproduced with permission by Oxford University Press from Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC. J Trop
Pediatr. 2000;46(3):132–139; ©Oxford University Press.
PEDIATRICS Volume 122, Number 2, August 2008 401
at Massachusetts General Hos on September 24, 2020www.aappublications.org/newsDownloaded from
Page 5
phages, lymph nodes, placenta, colon, breasts, osteoblasts,
activated macrophages, and keratinocytes, which suggests
an autocrine-paracrine role for 1,25(OH)2-D.
Epidermal melanin is a natural sunscreen that regu-
lates skin color and is synthesized from tyrosine by the
enzyme tyrosinase. After exposure to UV-B radiation,
melanin granules are transferred from melanocytes in
the epidermis to adjacent epidermal cells migrating to
the cell surface, which causes darkening of the skin. It
takes 2 weeks for a cell to migrate from the stratum
basale to stratum corneum and another 2 weeks for
stratum corneum cells to slough off. The concentration
of melanin in skin regulates how much UV-B penetrates
to reach the epidermal layers with the highest concen-
trations of 7-dehydrocholesterol (ie, stratum basale and
spinosum).55 Therefore, melanin protects against the risk
of skin cancer induced by excessive exposure to UVR
and also prevents UVR-induced photolysis of folate, a
metabolite necessary for normal development of the
embryonic neural tube and spermatogenesis. Therefore,
it imparts an evolutionary advantage to dark-skinned
people who live in areas of excessive sun exposure.58
However, a high melanin concentration can cause de-
creased vitamin D synthesis by preventing UV-B from
reaching the stratum basale and spinosum of the epider-
mis, and this risk becomes manifest in situations of in-
adequate sun exposure. It is important to note that
women of all populations have lighter skin than men,
presumably because of increased vitamin D and calcium
needs during pregnancy and lactation.59
UVR exposure to the skin is measured as the mini-
mum erythema dose (MED) or the amount of UVR
exposure that will cause minimal erythema (slight pink-
ness) of the skin. The amount of UVR exposure that is
equivalent to 1 MED depends on skin pigmentation, and
duration of exposure is factored into the MED. An en-
tire-body exposure to 1 MED is estimated to result in
release of 10 000 to 20 000 IU of vitamin D into the
circulation in 24 hours60,61 (reviewed in ref 56). Expo-
sure of 40% of the body to one-fourth MED will result in
generation of 1000 IU of vitamin D per day, the min-
imum amount of vitamin D synthesis necessary to main-
tain concentrations in the reference range.56
UV-B (290 –315 nm) has a shorter wavelength than
UV-A (320 – 400 nm) and is prone to scatter with oblique
rays earlier or later in the day; thus, little vitamin D is
produced in the skin at these times even in the summer
months.62 At solar noon (when the sun is at its zenith),
the ratio of UV-B to UV-A light is the highest, and the
only time that enough UV-B photons reach the earth’s
surface to produce vitamin D in the skin is between 1000
and 1500 hours in the spring, summer, and the fall.
Thus, safe sun exposure at these times is important.
Exposure time in the southern United States to achieve
1 MED at solar noon in the summer months is 4 to 10
minutes for pale skin, and 60 to 80 minutes for dark
skin.56 It should be noted that children, and particularly
infants, may require less sun exposure to produce suffi-
cient quantities of vitamin D because of greater surface
area for size and greater capacity to produce vitamin D
FIGURE 2
Vitamin D synthesis and processing. GH indicates growth hor-
mone. (Adapted with permission from Levine M, Zapalowski C,
Kappy M. Disorders of calcium, phosphate, parathyroid hor-
mone and vitamin D metabolism. In: Kappy MS, Allen DB,
Geffner ME, eds. Principles and Practice of Pediatric Endocrinol-
ogy. Springfield, IL: Charles C. Thomas Co; 2005:716, 719.)
402 MISRA et al at Massachusetts General Hos on September 24, 2020www.aappublications.org/newsDownloaded from